Hints and tips:
Pharma group seeks compensation from Covid vaccine maker for alleged IP infringements
Pharma group plans to make mRNA-based inoculation in Germany and ship it worldwide
UK pharma group has teamed up with South Korea’s SK Bioscience on jab that uses its adjuvant technology
...As well as partnering with Bayer to produce its Covid vaccine, CureVac has an agreement with the British pharma company GlaxoSmithKline to create a next generation of jabs....
...Following a meeting with pharma executives at the White House in early March, German media reported that the Trump administration had sought to lure the company, which also has a Boston base, to the US and...
...Large pharma companies like Sanofi and GSK are hoping to shake off their image as laggards, while start-ups such as Novavax, CureVac and Valneva see opportunities to satisfy unmet needs....
...When pharma companies were retrenching 10 years ago, he suspects early stage vaccine programmes were among those cut....
...Stefan Oelrich, the head of Bayer’s pharma division, said: “We are highly committed to making our capabilities and networks available to help end this pandemic.”...
...The UK-based pharma giant has been working with France’s Sanofi to develop a Covid-19 vaccine, and it has increased manufacturing capacity for its adjuvant, which can help give longer lasting immunity, in...
...UCB did not respond to requests for comment....
...Eisai alone has transferred licences for about 60 medicines to Germany — at a cost of about €7,200 each simply to change the name of the licence holder from “Eisai Europe in Hatfield” to “Eisai GmbH in Frankfurt...
...In the US, Nestlé’s Galderma unit markets a rival, known as Dysport, while Germany's Merz pharma sells a neurotoxin under the Xeomin brand....
...“[GSK chief executive] Emma Walmsley has been increasingly vocal about capital allocation and the prioritisation of investment in the pharma pipeline....
...industry heavyweights, including Pascal Soriot, chief executive of AZ, Philip Thomson, president of global affairs at GSK, Eric Nordkamp, UK head of Pfizer, and Jean-Christophe Tellier, chief executive of UCB...
...The carbonated version of the drink familiar to western consumers was created through a joint venture between TC Pharma and an Austrian partner in 1987....
...Arix also works with Brussels-based pharma group UCB....
...UCB, the Belgian pharmaceuticals group, says that its medicine, called romosozumab, is the first capable of rebuilding weakened bones....
...Botox is the leading wrinkle smoother, with a global market share of roughly 85 per cent, although dermatologists say it still faces fierce competition from drugs such as Nestlé’s Dysport and Merz Pharma...
...Jayne Spink Chief Executive, Tuberous Sclerosis Association Dr Neil Weir Senior Vice-President of Discovery Research, UCB Paul Wright Chief Executive, United Kingdom Science Park Association Dr Salman...
...UCB said the sale of its generics business would strengthen its push for new medicines. Lazard was lead financial adviser to UCB, with BNP Paribas providing additional support....
...Flemming Ørnskov, Shire chief executive, told the Financial Times he was focused on integration of NPS pharma, acquired for $5.2bn in January....
...Eli Lilly of the US, Takeda of Japan and UCB of Belgium are the others contributing compounds....
...Targets might include UK-listed Shire, Actelion of Switzerland and UCB of Belgium....
...UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing practices in the country....
...He said it could also dampen demand for UCB’s monoclonal antibody Cimzia....
International Edition